Loading clinical trials...
Loading clinical trials...
Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab
Conditions
Interventions
Elotuzumab
Dexamethasone
+5 more
Locations
41
United States
Local Institution - 0020
Tucson, Arizona, United States
Local Institution - 0017
Bakersfield, California, United States
Local Institution - 0022
Fountain Valley, California, United States
Local Institution - 0016
West Hollywood, California, United States
Local Institution - 0019
Denver, Colorado, United States
Local Institution - 0021
Jacksonville, Florida, United States
Start Date
July 15, 2016
Primary Completion Date
November 13, 2025
Completion Date
November 13, 2025
Last Updated
June 5, 2025
NCT06179888
NCT06152575
NCT04973605
NCT05201781
NCT06138275
NCT05862012
Lead Sponsor
Bristol-Myers Squibb
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions